Medicare Enrolled

Dr. Wieslaw Jakubowski, M.D.

Pediatrics · Corpus Christi, TX
Low-engagement
5920 SARATOGA BLVD, Corpus Christi, TX 78414
3619852111
In practice since 2006 (19 years)
NPI: 1164512075 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jakubowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jakubowski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jakubowski

Dr. Wieslaw Jakubowski is a pediatrics in Corpus Christi, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Jakubowski received a total of $6,032 from 35 pharmaceutical and/or device companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jakubowski is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $6,032 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,032
Total received (2018-2024)
Avg $862/year across 7 years
Top 2% in TX for pediatrics
35
Companies
128
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,032 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$980
2023
$778
2022
$626
2021
$628
2020
$413
2019
$1,415
2018
$1,193

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ironshore Pharmaceuticals Inc.
$613
Alexion Pharmaceuticals, Inc.
$473
GlaxoSmithKline, LLC.
$397
PFIZER INC.
$381
Biogen, Inc.
$377
Shire North American Group Inc
$327
Tris Pharma Inc
$323
Regeneron Healthcare Solutions, Inc.
$241
Travere Therapeutics, Inc.
$225
Neos Therapeutics, LP
$218
Corium, LLC
$207
GENZYME CORPORATION
$203
Mirum Pharmaceuticals, Inc.
$172
Merck Sharp & Dohme Corporation
$153
Supernus Pharmaceuticals, Inc.
$127
Pharming Healthcare, Inc.
$121
Retrophin, Inc.
$119
Corium, Inc.
$112
Gilead Sciences, Inc.
$109
Novartis Pharmaceuticals Corporation
$109
Teva Pharmaceuticals USA, Inc.
$105
Merck Sharp & Dohme LLC
$105
Phadia US Inc.
$104
Ultragenyx Pharmaceutical Inc.
$100
Kyowa Kirin, Inc.
$100
BioFire Diagnostics, LLC
$90
IRONSHORE PHARMACEUTICALS INC.
$80
SANOFI PASTEUR INC.
$75
Takeda Pharmaceuticals U.S.A., Inc.
$74
Genentech, Inc.
$73
Rhodes Pharmaceuticals L.P.
$49
ALK-Abello, Inc
$28
Adlon Therapeutics L.P.
$15
ARBOR PHARMACEUTICALS, INC.
$13
Mission Pharmacal Company
$13
Top 3 companies account for 24.6% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADHANSIA XR · AJOVY · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Azstarys · BEXSERO · BEYFORTUS · BioFire FilmArray · CIPRODEX · Cholbam · Crysvita · DUPIXENT · Dyanavel XR · ELAPRASE · EUCRISA · FABRAZYME · FLULAVAL · GARDASIL · Grastek · ILARIS · ImmunoCAP · JOENJA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kanuma · LUMIZYME · Livmarli · MENACTRA · MENQUADFI · MYDAYIS · PENTACEL · PREVNAR - 13 · PREVNAR 13 · Prednisolone 25 · QELBREE · Qelbree · Quillivant · ROTATEQ · SPINRAZA · Sklice · Spinraza · Strensiq · TRUMENBA · Thiola · VAXNEUVANCE · VPRIV · VYVANSE · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for pediatrics in TX.

Looking for a pediatrics in Corpus Christi?
Compare pediatricss in the Corpus Christi area by procedure volume, costs, and industry payment transparency.
Browse pediatricss nearby

Geographic Context

Pediatricss within 10 mi
128
Per 100K population
36.3
County median income
$66,021
Nearest hospital
CORPUS CHRISTI MEDICAL CENTER,THE
4.9 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jakubowski is a pediatrics, and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Jakubowski receive payments from pharmaceutical companies?
Yes. Dr. Jakubowski received a total of $6,032 from 35 companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Jakubowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatricss in Corpus Christi
Browse pediatricss in Corpus Christi ranked by procedure volume and transparency data.
Highest volume
Top Pediatricss in TX
Pediatricss ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatricss in TX
Which TX pediatricss receive the most from drug and device companies.
By company
Ironshore Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ironshore Pharmaceuticals Inc..
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc..
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →